Abbott Laboratories Stock Current Ratio
| ABL Stock | EUR 109.02 1.10 1.00% |
Abbott Laboratories fundamentals help investors to digest information that contributes to Abbott Laboratories' financial success or failures. It also enables traders to predict the movement of Abbott Stock. The fundamental analysis module provides a way to measure Abbott Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abbott Laboratories stock.
Abbott |
Abbott Laboratories Company Current Ratio Analysis
Abbott Laboratories' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Abbott Laboratories has a Current Ratio of 0.0 times. This indicator is about the same for the Other average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Abbott Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbott Laboratories' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics of similar companies.Abbott Laboratories is currently under evaluation in current ratio category among its peers.
Abbott Fundamentals
| Current Valuation | 190.22 B | |||
| Price To Book | 5.40 X | |||
| Price To Sales | 4.35 X | |||
| Revenue | 43.65 B | |||
| EBITDA | 12.13 B | |||
| Net Income | 6.93 B | |||
| Total Debt | 14.52 B | |||
| Cash Flow From Operations | 9.58 B | |||
| Price To Earnings To Growth | 18.64 X | |||
| Market Capitalization | 210.39 B | |||
| Total Asset | 74.44 B | |||
| Z Score | 8.4 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 74.44 B | |||
| Last Dividend Paid | 0.32 |
About Abbott Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Abbott Stock
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Abbott Stock, please use our How to Invest in Abbott Laboratories guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.